If you are a first-time drug user, we see you. If you are someone who uses drugs regularly, we see you. If you are a concerned parent, the child of a parent who uses, a friend, EMS, supporting a harm reduction program, or just concerned about people in your community,
WE SEE ALL OF YOU.
We understand substance use is multilayered and that it comes with inherent risk. Our goal for RiVive is for you to stay alive.
Harm Reduction Therapeutics
In moments of crisis
compassion RiVives®.
RiVive is strong enough to save lives with the lowest dose of OTC intranasal naloxone available in the United States, and it reduces the risk of precipitated withdrawal. RiVive offers Compassionate Overdose ResponseTM intended to rescue and not punish the person. Competitive products are formulated with higher doses of naloxone which can increase the risks of precipitated withdrawal symptoms caused from using more naloxone than may be necessary to reverse an overdose.
Harm Reduction Therapeutics, Inc. (HRT) is able to sell RiVive at a low price thanks to our status as the only 501(c)(3) non-profit pharmaceutical company that manufactures naloxone. Our manufacturing cost is our price, we make zero profit on RiVive.
“This allows us to SAVE AS MANY LIVES AS POSSIBLE THAT WOULD OTHERWISE BE LOST TO OPIOID OVERDOSE.”
Co-Founder & CEO
How to Administer
Learn how you can save lives with RiVive in 5 easy steps by watching this video.
Please only use as directed.
Our Mission
At Harm Reduction Therapeutics, our mission is rooted in compassion. We believe in a world where every life is valued, and where help is within reach for those facing the threat of overdose. With a deep sense of empathy and commitment, we developed RiVive, an OTC naloxone nasal spray to provide life-saving support when it’s needed most. Guided by the understanding that behind every statistic is a person, we bring accessible, compassionate care. Together we can help each other stay alive with RiVive.
Michael R. Hufford, PhD
Co-Founder & Chief Executive Officer
Proven to
Save Lives
- Avetian, et al. (2018) DOI: 10.1080/03007995.2017.1334637.
- Wheeler, E., et al., Opioid Overdose Prevention Programs Providing Naloxone to Laypersons, 2014.
- McClellan, C., et al., Opioid-overdose laws association with opioid use and overdose mortality. Addictive Behaviors, 2018. 86: p. 90-95.
- Townsend, T., et al., Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy, 2019.
- Naloxone has been shown to be successful in reversing overdoses in 98.8% of cases.1
- The CDC reports that tens of thousands of lives have been saved since 1996.2
- A national study showed overdose deaths decreased by 14% in states that enacted naloxone access laws.3
- Statistical modeling indicates that greater naloxone availability could reduce overdose deaths by 21%.4